why choose us

Course: Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States

CME Credits: 1.00

Released: 2021-07-02

SARS-CoV-2 and the resulting COVID-19 pandemic has affected more than 106 million people worldwide with more than 2.31 million deaths as of February 2021.1 Upon the emergency use authorization for a COVID-19 vaccine by the US Food and Drug Administration, the National Academies of Sciences, Engineering, and Medicine developed an overarching framework to assist US policy makers in planning for equitable allocation of COVID-19 vaccines.2 Minority populations have approximately 5 times greater risk of adverse COVID-19 consequences related to social determinants of health that may exacerbate patient comorbidities.4,6 Equitable distribution would eliminate vaccination disparities while mitigating the disproportionate effect of the COVID-19 pandemic in underserved populations, which are disadvantaged because of limited access to health care, low socioeconomic status, or race. This study aims to determine how every state planned to ensure equitable vaccine distribution.


Educational Objective
To identify the key insights or developments described in this article


View Full Course